Abstract
Glucose and lipid profile together with blood pressure should always be considered for low sera-IGF-1 patients. Even when adulthood is reached, IGF-1 therapy in these patients should be pursued as metabolic and protective cellular effects could be triggered. Real incidence of growth hormone insensitivity is still to be uncovered.
Author supplied keywords
Cite
CITATION STYLE
Castilla-Cortazar, I., Femat-Roldán, G., Rodríguez-Rivera, J., Aguirre, G. A., García-Magariño, M., Martín-Estal, I., … Díaz-Olachea, C. (2017). Mexican case report of a never-treated Laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and stroke. Clinical Case Reports, 5(11), 1852–1855. https://doi.org/10.1002/ccr3.1193
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
